Eqis Capital Management, Inc. Sanofi Transaction History

Eqis Capital Management, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$50.95 - $55.2 $959,286 - $1.04 Million	18,828 New	18,828 $1.01 Million
Q1 2021 May 14, 2021	SELL	$45.46 - $50.51 $189,659 - $210,727	-4,172 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$45.3 - $51.62 $188,991 - $215,358	4,172 New	4,172 $203,000
Q1 2020 May 12, 2020	SELL	$38.02 - $51.66 $189,985 - $258,145	-4,997 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$44.25 - $50.86 $26,417 - $30,363	-597 Reduced 10.67%	4,997 $251,000
Q3 2019 Nov 05, 2019	SELL	$40.34 - $46.64 $968 - $1,119	-24 Reduced 0.43%	5,594 $259,000
Q2 2019 Jul 18, 2019	SELL	$40.43 - $44.3 $19,244 - $21,086	-476 Reduced 7.81%	5,618 $243,000
Q1 2019 Apr 18, 2019	SELL	$40.83 - $45.43 $52,344 - $58,241	-1,282 Reduced 17.38%	6,094 $270,000
Q4 2018 Jan 25, 2019	SELL	$41.48 - $45.59 $4,687 - $5,151	-113 Reduced 1.51%	7,376 $320,000
Q3 2018 Oct 17, 2018	SELL	$40.0 - $44.84 $6,920 - $7,757	-173 Reduced 2.26%	7,489 $318,000
Q2 2018 Jul 27, 2018	SELL	$37.63 - $41.22 $6,660 - $7,295	-177 Reduced 2.26%	7,662 $307,000
Q1 2018 Apr 06, 2018	SELL	$38.98 - $45.76 $577,449 - $677,888	-14,814 Reduced 65.4%	7,839 $314,000
Q4 2017 Jan 25, 2018	SELL	$42.86 - $50.61 $35,145 - $41,500	-820 Reduced 3.49%	22,653 $974,000
Q3 2017 Oct 03, 2017	BUY	$47.04 - $50.34 $1.1 Million - $1.18 Million	23,473	23,473 $1.17 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.